PharmaCyte Biotech, Inc.
PMCB · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,932 | $8,427 | $11,136 | $13,823 |
| - Cash | $13,178 | $15,172 | $16,383 | $20,840 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6,247 | -$6,745 | -$5,247 | -$7,017 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,360 | -$1,042 | -$960 | -$1,106 |
| % Margin | – | – | – | – |
| Net Income | -$8,360 | $11,750 | -$3,045 | -$1,470 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.23 | 1.6 | -0.44 | -0.39 |
| % Growth | -176.9% | 463.6% | -12.8% | – |
| Operating Cash Flow | -$1,994 | -$1,040 | -$510 | -$1,055 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,994 | -$1,040 | -$510 | -$1,055 |